The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksI-nexus Global. Regulatory News (INX)

Share Price Information for I-nexus Global. (INX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.75
Bid: 2.50
Ask: 3.00
Change: 0.00 (0.00%)
Spread: 0.50 (20.00%)
Open: 2.75
High: 2.75
Low: 2.75
Prev. Close: 2.75
INX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

4 Nov 2020 11:15

RNS Number : 2557E
i-nexus Global PLC
04 November 2020
 

i-nexus Global PLC 

("i-nexus", the "Company" or the "Group")

Result of General Meeting

 

i-nexus Global plc (AIM: INX), a leading provider of cloud-based Strategy Execution software solutions designed for the Global 5000, is pleased to announce that further to its announcement on 19 October 2020, all resolutions put to shareholders at its General Meeting held today were duly passed.

Accordingly, the Directors have now been granted authority to issue the Convertible Loan Notes to the Investors. The Investors' commitments to subscribe for Convertible Loan Notes are now irrevocable and unconditional and settlement of the commitments of £1.325m is expected to take place later today.

Additionally, the Directors have been granted the required authority to disapply statutory pre-emption rights in respect of the potential future issue of new Ordinary Shares upon conversion of the Convertible Loan Notes. This disapplication shall expire on 5 November 2023.

Further announcements will be made upon conversion of the Convertible Loan Notes.

Capitalised terms used but not defined in this announcement have the meanings set out in the Announcement dated 19 October 2020.

 

For further information please contact:

 

 

 

i-nexus Global plc

Simon Crowther, CEO

Alyson Levett, CFO

 

Via: Alma PR 

 

N+1 Singer (Nominated Adviser and Broker)

Sandy Fraser (Corporate Finance)

Tom Salvesen (Corporate Broking)

 

Tel: +44 (0)207 496 3000

 

Alma PR

Caroline Forde / Josh Royston / Robyn Fisher

Tel: +44 (0)203 405 0212

 

 

 

 

 

 

 

 

 

 

     

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMFLFILLRLSIII
12
Date   Source Headline
26th Feb 20245:54 pmRNSResult of AGM
26th Feb 20247:00 amRNSAGM Statement
4th Jan 20245:53 pmRNSHolding(s) in Company
20th Dec 20237:00 amRNSFinal Results
17th Oct 20237:00 amRNSCustomer Update
7th Jul 202312:34 pmRNSResult of General Meeting
21st Jun 20237:00 amRNSProposed issue of up to £0.5 million
28th Apr 20237:00 amRNSInterim Results
3rd Mar 20239:28 amRNSHolding(s) in Company
27th Feb 202311:46 amRNSResult of AGM and current trading update
20th Dec 20227:00 amRNSFinal Results
11th Nov 20222:11 pmRNSGrant of LTIP options
3rd Oct 20221:31 pmRNSGrant of LTIP options
30th Sep 20223:12 pmRNSConvertible Loan Notes Redemption Date Extension 
2nd Aug 20228:00 amRNSFurther re Board Change
30th May 20227:00 amRNSInterim Results
24th May 20224:40 pmRNSSecond Price Monitoring Extn
24th May 20224:35 pmRNSPrice Monitoring Extension
12th May 20229:54 amRNSHolding(s) in Company
6th May 20222:00 pmRNSPrice Monitoring Extension
5th May 20227:00 amRNSAppointment of CFO
28th Apr 202212:20 pmRNSHolding(s) in Company
22nd Apr 20221:52 pmRNSHolding(s) in Company
28th Feb 202212:25 pmRNSResult of AGM and Trading Update
21st Dec 20217:00 amRNSFinal Results
29th Sep 202111:10 amRNSResult of General Meeting
13th Sep 20217:00 amRNSProposed issue of up to £0.65 million
2nd Sep 20212:41 pmRNSUpdate on trading and financial position
16th Jun 20214:41 pmRNSSecond Price Monitoring Extn
16th Jun 20214:35 pmRNSPrice Monitoring Extension
26th May 20217:00 amRNSInterim Results
18th May 20214:41 pmRNSSecond Price Monitoring Extn
18th May 20214:35 pmRNSPrice Monitoring Extension
18th May 20212:05 pmRNSSecond Price Monitoring Extn
18th May 20212:00 pmRNSPrice Monitoring Extension
22nd Apr 20214:41 pmRNSSecond Price Monitoring Extn
22nd Apr 20214:35 pmRNSPrice Monitoring Extension
22nd Apr 20212:06 pmRNSSecond Price Monitoring Extn
22nd Apr 20212:01 pmRNSPrice Monitoring Extension
20th Apr 20219:05 amRNSSecond Price Monitoring Extn
20th Apr 20219:00 amRNSPrice Monitoring Extension
20th Apr 20217:00 amRNSHolding(s) in Company
20th Apr 20217:00 amRNSStatement re Share Price Movement
19th Apr 20214:40 pmRNSSecond Price Monitoring Extn
19th Apr 20214:35 pmRNSPrice Monitoring Extension
19th Apr 20212:00 pmRNSPrice Monitoring Extension
16th Apr 20219:05 amRNSSecond Price Monitoring Extn
16th Apr 20219:00 amRNSPrice Monitoring Extension
29th Mar 20213:14 pmRNSDirector/PDMR Shareholding
25th Mar 20214:18 pmRNSResult of AGM
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.